LifeStance Health Group, Inc. Common Stock LFST
$12.62
-1.41%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $12.63
- Implied Upside
- +0.0%
- Price Target Range
- $8.00 – $18.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-09 | Canaccord GenuityRichard Close |
Maintains | Buy | $13 → $15 |
| 2026-08-19 | BTIGDavid Larsen |
Maintains | Buy | $16 → $18 |
| 2026-08-14 | JP MorganLisa Gill |
Maintains | Neutral | $9 → $13 |
| 2026-08-07 | BTIGDavid Larsen |
Maintains | Buy | $15 → $16 |
| 2026-07-24 | BTIGDavid Larsen |
Maintains | Buy | $12 → $15 |
| 2026-07-21 | Canaccord GenuityRichard Close |
Maintains | Buy | $11 → $13 |
| 2026-07-14 | BarclaysPeter Warendorf |
Maintains | Overweight | $9 → $13 |
| 2026-07-13 | KeybancSteve Dechert |
Maintains | Overweight | $11 → $13 |
| 2026-06-05 | Goldman SachsScott Fidel |
Initiates coverage on | Buy → Neutral | $9 |
| 2026-05-14 | JP MorganLisa Gill |
Maintains | Neutral | $8 → $9 |
| 2026-05-08 | BTIGDavid Larsen |
Maintains | Buy | $11 → $12 |
| 2026-03-06 | BarclaysPeter Warendorf |
Maintains | Overweight | $8 → $9 |
| 2026-02-26 | Canaccord GenuityRichard Close |
Maintains | Buy | $9 → $10 |
| 2026-02-26 | UBSKevin Caliendo |
Maintains | Buy | $10 → $12 |
| 2026-02-26 | KeybancScott Schoenhaus |
Maintains | Overweight | $8 → $9 |
| 2026-02-02 | BTIGDavid Larsen |
Maintains | Buy | $10 → $11 |
| 2025-12-12 | BTIGDavid Larsen |
Maintains | Buy | $9 → $10 |
| 2025-12-09 | BarclaysPeter Warendorf |
Initiates coverage on | Overweight | $8 |
| 2025-11-13 | BMO CapitalSean Dodge |
Initiates coverage on | Outperform | $8 |
| 2025-11-07 | UBSKevin Caliendo |
Maintains | Buy | $9 → $10 |
| 2025-11-06 | BTIGDavid Larsen |
Maintains | Buy | $8 → $9 |
| 2025-08-08 | UBSKevin Caliendo |
Maintains | Buy | $9 → $9 |
| 2025-05-27 | UBSKevin Caliendo |
Upgrades | Neutral → Buy | $9 |
| 2025-04-08 | KeybancSteve Dechert |
Initiates coverage on | Overweight | $9 |
| 2025-04-03 | Canaccord GenuityRichard Close |
Initiates coverage on | Buy | $8 |
| 2024-12-16 | Goldman SachsJamie Perse |
Upgrades | Neutral → Buy | $10 |
| 2024-11-11 | BarclaysStephanie Davis |
Maintains | Underweight | $6 → $7 |
| 2024-08-15 | UBSKevin Caliendo |
Maintains | Neutral | $9 → $8 |
| 2024-08-09 | BarclaysStephanie Davis |
Maintains | Underweight | $8 → $6 |
| 2024-04-22 | Morgan StanleyRicky Goldwasser |
Reiterates | Overweight | $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.62
- Market Cap
- $4.89 billion
- 52-Week Range
- $3.81 – $13.15
- Average Volume
- 4.33 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.